 Invitae is one of the worst-performing stocks in Cathie Woods Genomic Revolution ETF, down over 90 from the highs of 56.60 set in December 2020. The stock has become so cheap it now trades at under half of the book value and roughly 2.4x sales, despite massive revenue growth over the last five years. 